Finance

Lists
4521:TYO
Kaken Pharmaceutical Co Ltd
JP¥ ३,७०५.००
-०.९४%
(-३५.००) 1D
अक्टोबर ९, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Open
JP¥ ३,७५५
High
JP¥ ३,७५५
Low
JP¥ ३,७००
Mkt. cap
१.६४ खरब
Avg. vol.
१.०८ लाख
Volume
१.६७ लाख
Dividend
५.१३%
Quarterly dividend
JP¥ ४८
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१३.६१
52-wk high
JP¥ ४,४४५
52-wk low
JP¥ ३,५४०
EPS
JP¥ २७२
Shares outstanding
३.९७ करोड
No. of employees
१ हजार
Open
JP¥ ३,७५५
High
JP¥ ३,७५५
Low
JP¥ ३,७००
Mkt. cap
१.६४ खरब
Avg. vol.
१.०८ लाख
Volume
१.६७ लाख
Dividend
५.१३%
Quarterly dividend
JP¥ ४८
Ex-dividend date
२०२६ सेप्टेम्बर २९
P/E ratio
१३.६१
52-wk high
JP¥ ४,४४५
52-wk low
JP¥ ३,५४०
EPS
JP¥ २७२
Shares outstanding
३.९७ करोड
No. of employees
१ हजार
News stories
From web sources and news partners
The Business Journals
The Business Journals
·
२९ मिनेट पहिले
Axe Compute rings Nasdaq bell after pivoting from biotech to AI tokens
Altcoin Buzz
Altcoin Buzz
·
३१ मिनेट पहिले
Ripple-backed Evernorth debuts on Nasdaq with 473M XRP
Seeking Alpha
Seeking Alpha
·
३ मिनेट पहिले
3 things to look out for on Tuesday (SP500:)
About Kaken Pharmaceutical Co Ltd
CEO-
Employees१.११ हजार
Founded१९१७
Headquarters-
Sector-
Last report
२०२६ अगस्ट ७
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
३०.१६ अरब / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२०.४९ अरब
१८.२६ अरब
१९.२५ अरब
३०.१६ अरब
Cost of goods sold
८.७८ अरब
९.०१ अरब
१०.०९ अरब
९.१८ अरब
Cost of revenue
८.७८ अरब
९.०१ अरब
१०.०९ अरब
९.१८ अरब
Research and development expenses
६.२९ अरब
३.९७ अरब
४.९४ अरब
४.६० अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.२३ अरब
४.९२ अरब
४.९२ अरब
५.४७ अरब
Operating expense
११.५२ अरब
८.९० अरब
१०.६२ अरब
१०.०७ अरब
Total operating expenses
२०.३० अरब
१७.९१ अरब
२०.७१ अरब
१९.२५ अरब
Operating income
१८.७० करोड
३५.४० करोड
-१.४६ अरब
१०.९० अरब
Other non operating income
-२.७० करोड
३.४० करोड
४.३० करोड
८०.०० लाख
EBT including unusual items
९८.८० करोड
५८.८० करोड
३२.८० करोड
११.२४ अरब
EBT excluding unusual items
१८.४० करोड
५९.८० करोड
-१.४१ अरब
११.२६ अरब
Income tax expense
२६.७० करोड
१८.२० करोड
-४१.८० करोड
२.८० अरब
Effective tax rate
२७.०२%
-
-१२७.४४%
२४.९३%
Other operating expenses
-
-
-
-
Net income
७२.१० करोड
४०.६० करोड
७४.६० करोड
८.४४ अरब
Net profit margin
३.५२%
-
३.८७%
२७.९९%
Earnings per share
-
-
-
-
Interest and investment income
७.८० करोड
३२.४० करोड
९.१० करोड
३९.३० करोड
Interest expense
-१.१० करोड
-१.१० करोड
-१.३० करोड
-१.४० करोड
Net interest expenses
६.७० करोड
३१.३० करोड
७.८० करोड
३७.९० करोड
Depreciation and amortization charges
-
-
७५.२० करोड
-
EBITDA
९२.२० करोड
९९.२५ करोड
-६२.४८ करोड
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू